Evonik Industries AG (EVK):企業の財務・戦略的SWOT分析

◆英語タイトル:Evonik Industries AG (EVK) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDCH15267FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Chemicals
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Evonik Industries AG (EVK) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Evonik Industries AG (Evonik), a subsidiary of RAG-Stiftung, is a specialty chemical company. Its product portfolio includes surfactants, polymers, resins, additives and others. The company’s products find application in various markets, including agriculture, renewable energies, paints and coatings, paper and printings, metal and oil products, electrical and electronics food and animal feed, consumer and personal care products, pharmaceuticals, plastics and rubber, automotive and construction. It also offers process technology, technical, logistics, utilities and waste management, and engineering services. Evonik has major production facilities in Germany, Belgium, the US, China, and Singapore. The company has operations in North America, Asia-Pacific, Africa, South America, Europe and others. Evonik is headquartered in Essen, Nordrhein-Westfalen, Germany.

Evonik Industries AG Key Recent Developments

Mar 19,2021: Evonik and InnovationLab bring new battery technology to the market
Mar 10,2021: Evonik launches solutions to improve the performance and safety of electric vehicle batteries in China
Mar 09,2021: GET H2: New alliance aims to create the basis of a European infrastructure for green hydrogen
Feb 11,2021: Evonik strengthens strategic partnership with Biontech on covid-19 vaccine
Feb 11,2021: Evonik converts PU a dditives stabilizer portfolio to sustainable low VOC formulations

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Evonik Industries AG – Key Facts
Evonik Industries AG – Key Employees
Evonik Industries AG – Key Employee Biographies
Evonik Industries AG – Major Products and Services
Evonik Industries AG – History
Evonik Industries AG – Company Statement
Evonik Industries AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Evonik Industries AG – Business Description
Business Segment: Nutrition & Care
Overview
Performance
Business Segment: Performance Materials
Overview
Performance
Business Segment: Services
Overview
Performance
Business Segment: Smart Materials
Overview
Performance
Business Segment: Specialty Additives
Overview
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Central & South America
Performance
Geographical Segment: Europe, Middle East & Africa
Performance
Geographical Segment: North America
Performance
R&D Overview
Evonik Industries AG – Corporate Strategy
Evonik Industries AG – SWOT Analysis
SWOT Analysis – Overview
Evonik Industries AG – Strengths
Evonik Industries AG – Weaknesses
Evonik Industries AG – Opportunities
Evonik Industries AG – Threats
Evonik Industries AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Oil & Gas Financial Deals and Alliances
Evonik Industries AG, Petrochemicals, Deals By Year, 2015 to YTD 2021
Evonik Industries AG, Petrochemicals, Deals By Type, 2015 to YTD 2021
Evonik Industries AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 19, 2021: Evonik and InnovationLab bring new battery technology to the market
Mar 10, 2021: Evonik launches solutions to improve the performance and safety of electric vehicle batteries in China
Mar 09, 2021: GET H2: New alliance aims to create the basis of a European infrastructure for green hydrogen
Feb 11, 2021: Evonik strengthens strategic partnership with Biontech on covid-19 vaccine
Feb 11, 2021: Evonik converts PU a dditives stabilizer portfolio to sustainable low VOC formulations
Jan 11, 2021: Evonik begins marketing of natural refrigerants
Dec 09, 2020: Evonik’s Venture Capital unit buys minority stake in Chinese firm UnionTech
Nov 12, 2020: Extracting hydrogen from natural gas networks: Linde and Evonik offer joint technology solution
Oct 27, 2020: Evonik launches EUDRAGIT ready-to-use powder premix to improve processing, appearance and swallowability of oral drug products with an immediate release profile
Oct 15, 2020: Evonik delivers Q3 adjusted EBITDA of €519 million above market expectations
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Evonik Industries AG, Key Facts
Evonik Industries AG, Key Employees
Evonik Industries AG, Key Employee Biographies
Evonik Industries AG, Major Products and Services
Evonik Industries AG, History
Evonik Industries AG, Subsidiaries
Evonik Industries AG, Joint Venture
Evonik Industries AG, Key Competitors
Evonik Industries AG, Ratios based on current share price
Evonik Industries AG, Annual Ratios
Evonik Industries AG, Annual Ratios (Cont...1)
Evonik Industries AG, Annual Ratios (Cont...2)
Evonik Industries AG, Interim Ratios
Evonik Industries AG, Petrochemicals, Deals By Year, 2015 to YTD 2021
Evonik Industries AG, Petrochemicals, Deals By Type, 2015 to YTD 2021
Evonik Industries AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Evonik Industries AG (EVK):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EnPro Industries, Inc.:企業のM&A・事業提携・投資動向
    EnPro Industries, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EnPro Industries, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • EDF Renewables SA:企業の戦略的SWOT分析
    EDF Renewables SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Syntimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Syntimmune Inc (Syntimmune) is a clinical-stage biotechnology company that focuses to develop Fc receptor (FcRn) based antibody therapeutics for the treatment of autoimmune diseases. Its lead pipeline products includes SYNT001, an investigational humanized IgG4 monoclonal antibody that inhib …
  • Kyocera Corporation:企業の戦略・SWOT・財務情報
    Kyocera Corporation - Strategy, SWOT and Corporate Finance Report Summary Kyocera Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Aeon Global Health Corp (ADAT)-医療機器分野:企業M&A・提携分析
    Summary Aeon Global Health Corp (Aeon), formerly Authentidate Holding Corp is a clinical lab and healthcare services organization that offers diagnostic services in cancer genomics, toxicology, pharmacogenomics, and health technology applications. The organization offers clinical laboratory services …
  • Exact Sciences Corp (EXAS)-医療機器分野:企業M&A・提携分析
    Summary Exact Sciences Corp (Exact) is a molecular diagnostic company that focuses on the early detection and prevention of various cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of …
  • Eureka Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Eureka Therapeutics Inc (Eureka Therapeutics) which focuses on the development of novel T cell immunotherapies for the treatment of solid tumors. Its pipeline encompasses drug candidates for various indications such as liver cancer, hematological cancer, lung cancer, head and cervical cancer …
  • TearLab Corp (TEAR):製品パイプライン分析
    Summary TearLab Corp (TearLab) is an ophthalmic device company. It commercializes a proprietary in vitro diagnostic tear testing platform. The company’s flagship TearLab osmolarity system measures the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in patients. Its osmolar …
  • Carisma Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Carisma Therapeutics Inc (Carisma Therapeutics), formerly CARMA Therapeutics LLC, is a biotechnology company with focus on the discovery and development of macrophage-based immunotherapeutics for the treatment of cancer. The company exploits its proprietary CAR-macrophage platform to provide …
  • Hess Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Hess Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Hess Corp (Hess) is a global independent energy company which carries out the exploration and production of crude oil and natural gas. It primarily operates in US, Denmark, the Joint Development Area of Ma …
  • Alabama Power Co:発電所・企業SWOT分析
    Alabama Power Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Forestar Group Inc:企業の戦略・SWOT・財務情報
    Forestar Group Inc - Strategy, SWOT and Corporate Finance Report Summary Forestar Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • LVMH Moet Hennessy Louis Vuitton SA:企業の戦略・SWOT・財務情報
    LVMH Moet Hennessy Louis Vuitton SA - Strategy, SWOT and Corporate Finance Report Summary LVMH Moet Hennessy Louis Vuitton SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Core Laboratories NV (CLB):企業の財務・戦略的SWOT分析
    Core Laboratories NV (CLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Brokk AB:企業の戦略的SWOT分析
    Brokk AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Clinigen Group Plc (CLIN):企業の財務・戦略的SWOT分析
    Summary Clinigen Group Plc (Clinigen Group) operates as a pharmaceutical and services company that provides access to clinical trials, medicines, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines such as foscavir, cardioxane, ethyol, savene and vibati …
  • Oncodesign SA (ALONC):企業の財務・戦略的SWOT分析
    Summary Oncodesign SA (Oncodesign) is a bio pharmaceutical company that discovers drugs to treat diseases with unmet medical needs. It is investigating LRRK2 inhibitor to treat Parkinson’s disease, RIPK2 inhibitor against autoimmune diseases, MNK1/2 inhibitor targeting cancer. The company offers dru …
  • Blue Nile, Inc.:企業の戦略・SWOT・財務情報
    Blue Nile, Inc. - Strategy, SWOT and Corporate Finance Report Summary Blue Nile, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • JXTG Holdings, Inc.:企業の戦略・SWOT・財務分析
    JXTG Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary JXTG Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Peptilogics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Peptilogics Inc (Peptilogics) is an early-stage biotechnology company that develops novel peptide therapeutics. The company’s antibiotics address the epidemic of multidrug-resistant bacterial infections. Its products portfolio includes engineered Cationic Antibiotic Peptides (eCAP) technolog …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆